|
Proceedings -Thursday, October 10, 2002
TuOA1: Plenary
The Economics of Pharmaceutical Innovation: Trends in Costs, Risks and Returns
Joseph A. DiMasi, Ph.D. Director of Economic Analysis, Tufts Center for the Study of Drug Development
Premise:
The perspectives of another sponsor, Solvay Pharmaceuticals, are shared
in this presentation which focused on strategies for achieving success
in working with CROs. Solvay has a small bioanalytical staff and the
role of CROs to their development effort is vital; proper communication
and monitoring are important to a successful study outcome. The topics
discussed in this presentation included: Why Outsource, Obtaining
Good Quotes, CRO Selection, Study Initiation, Effective Study Monitoring,
Data Delivery and Obtaining Useful Reports.
Discussion
Outsourcing is a necessary function when the availability of in-house
staff is limited, study size is larger than present analytical capacity,
special requirements exist for the analysis, and for strategic reasons.
Expectations between the sponsor and CRO must be shared and understood
in order for a successful study to be conducted. Some of the important
study parameters to be communicated include:
- Confidentiality Agreement
- Method Requirements (development, validation, transfer)
- Assay Range
- Study Specifics
- Data Delivery Expectations
- Bioanalytical Report Expectations
A pre-study site visit by the sponsor is very important and highly
recommended. At this visit, technical capabilities are assessed (both
in terms of personnel and the facility), the capabilities for achieving
quality are evaluated, compliance with current regulations and guidance
documents is assessed, and the upcoming study is discussed. How is
a CRO selected? Many factors go into this decision including an evaluation
of the fit of CRO strengths to the project goals and various quality
and project management issues. Solvay's experience suggests that "cheaper
is not always better." Various tasks and activities are recommended at different stages of
the process in working with a CRO to meet project goals.
Pre-Study Tasks
- Identify primary contacts at both sites
- Define expectations for progress updates
- Study plan documented in detail In-Study Activities
- Periodic progress reports (establish content and frequency)
- Site visit while study is ongoing to monitor activities
- Interim non-QA'd data transmissions to bioanalytical study monitor
- Inform CRO of any mid-study changes
Data Delivery
- QA'd data is always preferred
- Request to be copied on all data transfers
- Anticipate and relate questions from recipient Bioanalytical Report
- Request a draft for comment
- In-house technical and quality review
- In-house content requirements
- Incorporate final report into in-house electronic database
Lessons Learned
Lessons learned in working with CROs over the years were discussed.
One important point is that the technical expertise at the CRO and
at the sponsor site is critical; the capabilities and the understanding
of the needs and analytical solutions must exist so that data obtained
are meaningful and valid. Communication must be timely; when time
lapses without any contact, there may be real problems occurring or
clarification/-direction may be needed. Any anomalies must be shared
and reported, such as sample volumes smaller than expected, samples
left unanalyzed (ask "why?"), inconsistent report formatting
and/or errors in QA'd data.
In addition to communication between the sponsor and CRO, the communication
within the CRO is very important. The CRO project manager must be
capable and effective at managing the sponsor's project. Internal
resources must be defined and secured, and scheduling needs to be
managed daily; timeliness and report deadlines must also be monitored.
That project manager represents the sponsor's needs and interests
and is the liaison to resulting in a successful study conclusion.
Keys to Success
Overall, arranging for and managing a study between a sponsor and
a CRO is an important task that takes much planning, research and
time. Some of the keys to success identified by Solvay Pharmaceuticals
include:
- Clear points of contact are established at both sites
- Details are well defined prior to study initiation
- Deliverables are clearly understood
- Regular communication occurs between the sponsor and CRO
Return to Proceedings »
|